Navigation Links


Urological in Medical Technology

Cryoablation Is Focus of 17 Clinical Studies at American Urological Association Annual Meeting

M.D. Anderson, Cleveland Clinic Among Group of Leading Cancer Centers Presenting Cryoablation Data IRVINE, Calif., May 21 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO ), an innovative medical device company focused on the development of minimally invasive techn...

Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association

94 Percent of Men Maintained Normal Testosterone Levels Throughout Treatment 92 Percent of Men Expressed Satisfaction with NEBIDO LEXINGTON, Mass., May 20 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV ) today announced that dat...

Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association

* Ozarelix Effective in Improving Symptoms and Urine Flow, With Long Lasting Effect in Phase 2 Study IRVINE, Calif., May 23, 2007 /PRNewswire-FirstCall/ -- Spectrum Pharmaceuticals, Inc., today announced Phase 2 safety and efficacy data for ozarelix, the Company's drug candidate for the treatment ...

Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis

... U.S. Regulatory Approval - SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Eight studies presented this week at the annual meeting of the American urological Association (AUA) suggest that Gen-Probe's (Nasdaq: GPRO ) investigational test for the highly specific prostate cancer gene PCA3 may help address s...

Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer

... WASHINGTON, April 29 /PRNewswire-USNewswire/ -- The recent announcement of the REDUCE trial results at the American urological Association annual meeting in Chicago brings optimism to the prostate cancer community as dutasteride (Avodart), a drug used to treat benign prostatic...

Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer

...w results to be presented April 28 at the American urological Association (AUA) Annual Scientific Meeting in Chi...d the session in person. About the American urological Association: Founded in 1902 and headquartered near Baltimore , Maryland , the American urological Association is the pre-eminent professional organi...

Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study

...ced prostate cancer met its primary endpoint of significantly improving overall survival compared to placebo. The data were presented at the American urological Association (AUA) Annual Meeting. The intent-to-treat analysis demonstrated that: PROVENGE extended median survival by 4.1 mo...

Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia

... -- Data Presented at American urological Association Annual Meeting -- SEATTLE and CHICAGO, April 28 /PRNewswir...D-3263 for Benign Prostatic Hyperplasia" is being presented at the American urological Association's (AUA) 2009 Annual Meeting in Chicago, IL, today in a poster s...

AUA Guideline: Full Kidney Removal Not Necessary for All Kidney Tumors

...to a new clinical guideline issued by the American urological Association (AUA). The guideline was released on T...e Andrew C. Novick, MD. About the American urological Association: Founded in 1902 and headquartered near Baltimore , Maryland , the American urological Association is the pre-eminent professional organi...

Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms

...he 104th Annual Scientific Meeting of the American urological Association (AUA) showing that generic substitutes...9: 181, 4, abstract 1799 About the American urological Association: Founded in 1902 and headquartered near Baltimore , Maryland , the American urological Association is the pre-eminent professional organi...

New Body of Research Suggests Statin Use Benefits Multiple Areas of Urologic Health

.../ -- Several new studies presented at the American urological Association's (AUA) 104th Annual Scientific Meetin...he 104th Annual Scientific Meeting of the American urological Association (AUA). The following study findi...w"> LDean@AUAnet.org . About the American urological Association: Founded in 1902 and headquartered ...

Increased Mortality Associated With Nocturia

...he 104th Annual Scientific Meeting of the American urological Association (AUA) showing that there was a signifi...09: 181, 4, abstract 20. About the American urological Association: Founded in 1902 and headquartered near Baltimore , Maryland , the American urological Association is the pre-eminent professional organi...

Obesity Associated With Higher Risk for Urinary Tract Infections

...he 104th Annual Scientific Meeting of the American urological Association (AUA), assesses and stratifies this ri...: 181, 4, abstract 395. About the American urological Association: Founded in 1902 and headquartered near Baltimore , Maryland , the American urological Association is the pre-eminent professional organi...

Men Treated for Localized Prostate Cancer Could Benefit From Pomegranate Juice Consumption

...he 104th Annual Scientific Meeting of the American urological Association (AUA). Researchers found that men who ...9: 181, 4, abstract 826. About the American urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American urological Association is the pre-eminent professional organi...

Adult Circumcision Reduces Risk of HIV Transmission Without Reducing Sexual Pleasure

...he 104th Annual Scientific Meeting of the American urological Association (AUA) show that adult circumcision red...: 181, 4, abstract 1041. About the American urological Association: Founded in 1902 and headquartered near Baltimore , Maryland , the American urological Association is the pre-eminent professional organi...

Ferring Pharmaceuticals Launches Phase IIIB Trial of Degarelix as Intermittent Therapy

... Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer. The announcement was made at the 2009 American urological Association Annual Meeting in Chicago, IL. The Phase IIIB trial will investigate the use of degarelix for intermittent androgen deprivation thera...

Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers

...inics of Minnesota - Pine Tree Apple Tennis Classic, Washington University Department of Pathology, St. Louis Children's Hospital Foundation and the urological Research Foundation supported this research. Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also ar...

CEL-SCI Corporation Releases Letter to Shareholders

...t of improving overall survival compared to a placebo control. The full data from the 512 patient study will be presented on April 28 at the American urological Association conference. The significance of Dendreon's success to CEL-SCI is great. For years most investors have shunned the cancer immunothera...

Freezing Prostate Cancer Does a Man's Body Good

..., who works in consultation with urologists. Doctors should discuss cryoablation with patients early on, he advised, noting that recently the American urological Association issued a best practice statement that indicated that cryotherapy is an option for men who have clinically organ-confined prostate cancer o...

Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology

...oped for the UroCool(TM) catheter has a number of potential future clinical applications for tissue cooling in the pelvic region. These include other urological procedures such as radical cystectomy, a common procedure used to treat bladder cancer that has spread into the bladder wall. There are also a numb...

Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease

...tified 1,402 men who lived in Olmsted County, Minn., in 1996 and did not have heart disease. Every two years for 10 years, these men were assessed for urological and sexual health. Answers to questions from the Brief Male Sexual Function Inventory, a statistically validated questionnaire, were used to dete...

Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program

...e derived from its proprietary PharmacoSurgeryTM platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgeryTM clinical development programs, and its lead product candidate, O...

ProUroCare Medical Inc. Announces Pricing of Equity Offering

...nc. is a development stage company engaged in the business of developing for market innovative products for the detection and characterization of male urological prostate disease. The Company's primary focus is currently the ProUroScan prostate imaging system, which is now in clinical trials. ...

Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial

...nerstone to our U.S. reimbursement efforts, and is part of a very focused strategy to solidify reimbursement coverage for PTNS. Recently, the American urological Association published the American Medical Association's (AMA) advice to the medical community that their previously recommended "listed" CPT code for...

New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes

.... The core therapeutic areas in Orion's product and research strategy are central nervous system disorders, cardiology, critical care and hormonal and urological therapies. Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer ...

Omeros and The Parkinson's Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders

...derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, ...

Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302

...perative joint function and reduce pain following arthroscopic surgery. The urological PharmacoSurgery(TM) product candidate OMS201, currently in a fully enrolled...ve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing Pharmaco...

Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery

...derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, ...

The ED Conversation Dilemma: Forty Percent of Men with ED Don't Talk to Their Doctor, Survey Finds

...nt-area/erectile_dysf.asp#q1 . Last accessed April 8, 2008. (2) American urological Association. "2006 Annual Meeting Highlights". http://www.auanet.org/cme/amhighlights/sffa.pdf . Last accessed June 9, 2008. (3) American urological Association. "Non-surgical management of erectile dysfunction." http://www...

TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra, Levitra and Cialis Type Tablets

... ORLANDO, Fla., June 5 /PRNewswire/ -- New research presented at the recent American urological Association Conference by Urologist Joel L. Marmar, M.D., showed that among men who previously failed to achieve erections on Viagra, Levitra and Cial...

Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder

...nical data on two Phase 3 products at the American urological Association's annual meeting. The abstracts includ...atments that not only treat the symptoms of common urological conditions but also offer patients quality of life... disorders. By advancing education and support for urological diseases, we are creating the differences that mak...

Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia

... - Data Presented at American urological Association Annual Meeting - SEATTLE and ORLANDO, Fla., May 21 /PRNewswir...arget for Benign Prostatic Hyperplasia," is being presented at the American urological Association's 2008 Annual Meeting in Orlando, Fla., on Wednesday, May 21, 2...

Uroplasty Highlights Clinical Results From a Study of the Urgent(R) PC Neuromodulation System

...ologist Presents OrBIT Study Results Comparing Percutaneous Tibial Nerve Stimulation with Pharmaceutical Therapy at the 2008 American urological Association Annual Meeting MINNEAPOLIS, May 21 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufa...

Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study

...Surgery(TM) drug product candidate, for use during urological surgery. At least 24 patients undergoing unilatera...cedures. Added to standard irrigation solutions in urological surgery, OMS201 is delivered during the operation ...atients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros ...

Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause

.... The core therapeutic areas in Orion's product and research strategy are central nervous system disorders, cardiology, critical care and hormonal and urological therapies. Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer ...

Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia

... conditions ranging from overactive bladder to prostate cancer, Watson continues to support research that not only treats the symptoms associated with urological conditions, but that helps make urology patients' lives more livable. The Watson portfolio in the U.S. includes Oxytrol(R); Trelstar(R) LA; Trelstar(R...

New Data Presented on the Renessa(R) Treatment for Female Stress Urinary Incontinence

...rability study presented at Western Section meeting of the American urological Association NEWARK, Calif., Nov. 9 /PRNewswire/ -- Novasys Medical, Inc.,...(SUI) in women was presented at the Western Section meeting of the American urological Association (AUA). A total of 137 women in the trial have been treated at 1...

Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial

...for the year ended September 30, 2006. Rochester Medical Corporation develops, manufactures, and markets disposable medical catheters and devices for urological and continence care applications. The Company markets under its own Rochester Medical(R) brand and under existing private label arrangements. For fur...

Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years

...mptom improvement was measured using the International Prostate Symptom Score (IPSS), a validated assessment questionnaire recommended by the American urological Association (AUA). Over 24 months, AVODART and tamsulosin combination therapy provided a significantly greater (p < 0.001) improvement in symptoms (IP...

Positive Clinical Data for TASQ - Active Biotech's Novel Treatment of Prostate Cancer

... velocity compared to prior treatment. Three of these five patients exhibited a decrease in absolute PSA levels. The study is being performed at the urological clinics at the University Hospitals in Lund, Malmö and Uppsala, Sweden. The objective of the TASQ project is to develop a pharmaceutical produc...
Other TagspowerssufferersTutTutTutTutTutOther Contentscutaneouscutaneouscutaneouscutaneouscutaneouscuspidcyanosiscyanidecyanidecyanoticacneacneacnecysticcysticcysticcysticcysticcysticcysticcysticcystic